Delivery Order SPE2DE21D7009-SPE2D626F45H5
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,877.20 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of December 29, 2025, and will be performed in Valencia, California. The award carries no small business set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $36,589.22 on September 9, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of September 19, 2025, and is being performed in Valencia, California. The award carries no set-aside designation, indicating open competition in the federal marketplace. The contract is funded through the Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a delivery order valued at $31,806.25 for pain management medical devices on November 28, 2025, with an ultimate completion date of December 17, 2025. This fixed-price delivery order with economic price adjustment was issued by the Defense Logistics Agency's Medical Supply Chain division under the company's larger indefinite delivery contract (SPE2DE), valued at $83.1 million through August 16,...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $31,771.22 for pain management medical devices on November 28, 2025, under a Defense Logistics Agency Troop Support Medical contract. The delivery order, which is fixed-price with economic price adjustment provisions and carries an ultimate completion date of December 5, 2025, represents a task order against the company's larger indefinite delivery contract (SPE2DE)...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $26,980 delivery order on November 28, 2025, for pain management medical devices and services. The contract, which carries a fixed-price structure with economic price adjustment provisions, is scheduled for completion by December 5, 2025, and will be performed in Valencia, California. This delivery order was issued without a set-aside designation and is funded through the Defense Department's...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $1,867 fixed-price delivery order with economic price adjustment on September 9, 2025, for pain management medical devices. The contract is set to be completed by September 16, 2025, with performance taking place in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $1,867.00 on December 15, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment authority has an ultimate completion date of February 6, 2026, and will be performed in Valencia, California. The award was made without a set-aside designation by the Medical Supply Chain, a defense-related procurement entity within...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $1,825.75 on November 28, 2025, for pain management medical devices and services. This fixed-price delivery order with economic price adjustment authority is performance-based in Valencia, California, and carries an ultimate completion date of December 5, 2025. The contract was awarded by the Medical Supply Chain, a defense-related procurement entity under the Department of...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $1,825.75 delivery order for pain management medical devices under contract 4570282591. The award, issued on November 28, 2025, with an ultimate completion date of December 5, 2025, utilizes a fixed-price contract with economic price adjustment pricing structure. The contract is not designated for any small business set-aside and will be performed in Valencia, California. This delivery order...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $1,825.75 for pain management medical devices under a fixed-price contract with economic price adjustment. The award was issued on May 8, 2025, with an ultimate completion date of May 16, 2025, and will be performed in Valencia, California. This delivery order is issued under the company's larger indefinite delivery contract with the Defense Logistics Agency Troop...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D626F45H5Delivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $31,771.22 fixed-price delivery order (Contract No. 4570331497) on December 15, 2025, for pain management medical devices and related services. The award carries an economic price adjustment clause and is scheduled for completion by December 29, 2025. This delivery order was issued under the company's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop Support Medical branch, valued at $83.1 million through August 16, 2026. The contract involves no set-aside designation and will be performed at the contractor's facility in Valencia, California, supporting the Medical Supply Chain, a defense-related procurement entity within the Department of Defense. The delivery order continues Boston Scientific Neuromodulation's established role as a primary supplier of advanced neuromodulation solutions to military treatment facilities and Veterans Affairs medical centers nationwide. The company specializes in non-opioid pain management technologies, including spinal cord stimulation systems, implantable pain pumps, radiofrequency ablation devices, and associated medical equipment designed to help service members and veterans manage chronic pain. This award reflects the federal government's ongoing confidence in Boston Scientific's capability to deliver specialized, sophisticated medical devices and technical support services that address critical pain management needs across the defense and veterans healthcare enterprises.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.8k | 12/14/25 |